within Pharmacolibrary.Drugs.ATC.A;

model A01AB16
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 1.2 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Mepartricin is a polyene macrolide antifungal drug primarily used in the treatment of infections caused by Candida, Trichomonas, and Gram-positive bacteria. It has also been investigated for conditions such as benign prostatic hyperplasia and chronic prostatitis. Mepartricin is no longer widely approved or used in most countries today.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies or parameters for mepartricin were found in the scientific literature as of 2024.</p><h4>References</h4><ol><li><p>Del Vecchio, S, et al., &amp; Ricci, GL (1990). Faecal elimination of steroids in rats after oral administration of mepartricin. <i>The Journal of international medical research</i> 18(6) 468â€“472. DOI:<a href=&quot;https://doi.org/10.1177/030006059001800604&quot;>10.1177/030006059001800604</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2292328/&quot;>https://pubmed.ncbi.nlm.nih.gov/2292328</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A01AB16;
